Unlike the pound, the euro has benefitted from the fall in the global markets. The acceleration of vaccine programmes across the continent is also supporting the single currency.
Johnson & Johnson will restart their shipment of vaccines to the EU after the European Medicines Agency said that the link to blood clots are very rare. There were initial concerns about the link to blood clots, however the EMA has now said that the benefits outweigh the risk.
This should mean that European countries are now able to ramp up their vaccine rollouts further.
